Nanox Revenue Jumps 54% in Q1 2026

Key Facts

Amid ongoing growth in the emerging medical imaging sector, Nanox (NNOX) reported Q1 2026 results showing a 54% year-over-year revenue increase. According to preliminary company data, revenue reached $4.3 million compared to $2.8 million in Q1 2025, reflecting commercial expansion despite the absence of profitability data.

The growth comes at a time when the medical imaging sector faces competitive pressures, with peers such as Butterfly Network and Siemens Healthineers showing mixed performance recently. However, no direct profitability comparisons are available, limiting the ability to assess Nanox's relative performance.

In trading, NNOX closed at $1.67 on June 18, 2026, impacted by a broader downturn in small-cap stocks. No near-term catalysts are clearly visible, though markets await updates on the rollout of the novel "Nanox.ARC" imaging technology and annual revenue guidance.